Proteomics in rheumatology

The dawn of a new era

Kamala Vanarsa, Chandra Mohan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Most rheumatic autoimmune diseases are complex in terms of their genetic origins and underlying pathogenic processes. Non-hypothesis-driven scanning platforms are adding novel insights to our understanding of these multifactorial diseases. This review summarizes the handful of recent proteomic studies that have been executed using samples from patients with rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, or Sjogren's syndrome. The candidate biomarkers that have been uncovered in the reviewed studies have potential applications in diagnosis, prognosis, and theranostics. Though we are at the infancy of the proteomics era in rheumatology, the limited number of molecules uncovered thus far already hold promise. Ongoing research in proteomics holds tremendous potential for shaping how rheumatic diseases are diagnosed, prognosticated, and managed clinically over the coming years.

Original languageEnglish (US)
Article numberM2-87
JournalF1000 Medicine Reports
Volume2
Issue number1
DOIs
StatePublished - Dec 8 2010

Fingerprint

Rheumatology
Proteomics
Rheumatic Diseases
Ankylosing Spondylitis
Sjogren's Syndrome
Osteoarthritis
Systemic Lupus Erythematosus
Autoimmune Diseases
Rheumatoid Arthritis
Biomarkers
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Proteomics in rheumatology : The dawn of a new era. / Vanarsa, Kamala; Mohan, Chandra.

In: F1000 Medicine Reports, Vol. 2, No. 1, M2-87, 08.12.2010.

Research output: Contribution to journalArticle

Vanarsa, Kamala ; Mohan, Chandra. / Proteomics in rheumatology : The dawn of a new era. In: F1000 Medicine Reports. 2010 ; Vol. 2, No. 1.
@article{fba5977803c44caaa4d33cdb8ce00bdf,
title = "Proteomics in rheumatology: The dawn of a new era",
abstract = "Most rheumatic autoimmune diseases are complex in terms of their genetic origins and underlying pathogenic processes. Non-hypothesis-driven scanning platforms are adding novel insights to our understanding of these multifactorial diseases. This review summarizes the handful of recent proteomic studies that have been executed using samples from patients with rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, or Sjogren's syndrome. The candidate biomarkers that have been uncovered in the reviewed studies have potential applications in diagnosis, prognosis, and theranostics. Though we are at the infancy of the proteomics era in rheumatology, the limited number of molecules uncovered thus far already hold promise. Ongoing research in proteomics holds tremendous potential for shaping how rheumatic diseases are diagnosed, prognosticated, and managed clinically over the coming years.",
author = "Kamala Vanarsa and Chandra Mohan",
year = "2010",
month = "12",
day = "8",
doi = "10.3410/M2-87",
language = "English (US)",
volume = "2",
journal = "F1000 Medicine Reports",
issn = "1757-5931",
publisher = "Medicine Reports Limited",
number = "1",

}

TY - JOUR

T1 - Proteomics in rheumatology

T2 - The dawn of a new era

AU - Vanarsa, Kamala

AU - Mohan, Chandra

PY - 2010/12/8

Y1 - 2010/12/8

N2 - Most rheumatic autoimmune diseases are complex in terms of their genetic origins and underlying pathogenic processes. Non-hypothesis-driven scanning platforms are adding novel insights to our understanding of these multifactorial diseases. This review summarizes the handful of recent proteomic studies that have been executed using samples from patients with rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, or Sjogren's syndrome. The candidate biomarkers that have been uncovered in the reviewed studies have potential applications in diagnosis, prognosis, and theranostics. Though we are at the infancy of the proteomics era in rheumatology, the limited number of molecules uncovered thus far already hold promise. Ongoing research in proteomics holds tremendous potential for shaping how rheumatic diseases are diagnosed, prognosticated, and managed clinically over the coming years.

AB - Most rheumatic autoimmune diseases are complex in terms of their genetic origins and underlying pathogenic processes. Non-hypothesis-driven scanning platforms are adding novel insights to our understanding of these multifactorial diseases. This review summarizes the handful of recent proteomic studies that have been executed using samples from patients with rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, or Sjogren's syndrome. The candidate biomarkers that have been uncovered in the reviewed studies have potential applications in diagnosis, prognosis, and theranostics. Though we are at the infancy of the proteomics era in rheumatology, the limited number of molecules uncovered thus far already hold promise. Ongoing research in proteomics holds tremendous potential for shaping how rheumatic diseases are diagnosed, prognosticated, and managed clinically over the coming years.

UR - http://www.scopus.com/inward/record.url?scp=78650483064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650483064&partnerID=8YFLogxK

U2 - 10.3410/M2-87

DO - 10.3410/M2-87

M3 - Article

VL - 2

JO - F1000 Medicine Reports

JF - F1000 Medicine Reports

SN - 1757-5931

IS - 1

M1 - M2-87

ER -